ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

IXI Ixico Plc

8.125
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Ixico Plc LSE:IXI London Ordinary Share GB00BFXR4C20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 8.125 8.00 8.25 8.125 8.125 8.13 4,829 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Ixico Share Discussion Threads

Showing 626 to 647 of 700 messages
Chat Pages: 28  27  26  25  24  23  22  21  20  19  18  17  Older
DateSubjectAuthorDiscuss
07/2/2023
12:58
Wow!! great results and now turning a corner as prospects and sales improve. IXI can now start heading towards previous highs.

They now have the AI Products and Services and strong interest in sales. Many companies are setting lower targets so they can beat market expectations with IXI next level of resistance 40p then once broken 60p plus more as orders start flowing in.

Future looking very bright with strong AI solutions which are in High Demand.

halfpenny
07/2/2023
07:19
Trading Update - So revenue for this year expected to be 7 million, and EBITDA loss of GBP 1.1 million and revenue for next year to be 10% higher. That would still be a loss for next year.

Of course if the C suite were not so outrageously paid, then would only be a small loss this year and decently paid next year.

A radical board and management change is required here.

40 fathoms
09/12/2022
11:39
@Cliff, thanks.
casholaa
09/12/2022
09:09
Presentation now back up on YouTube
cliffpeat
09/12/2022
08:53
Maybe it was related to this, which was released during the day, yesterday. It is the Phase II contracts they are hoping to convert in to the much more substantial Phase III contracts, so it knocks out one of the contracts they could potentially convert.

8 December 2022

IXICO plc ("IXICO" or the "Company")

Contract update

IXICO plc (AIM: IXI), the precision analytics company delivering intelligent insights in neuroscience, announces that it has been notified by a client that the client has decided to discontinue a phase two trial that was previously announced by the Company. While this is expected to result in a reduction in management's previously anticipated revenues for 2023 of £0.1m and a total reduction in the Company's orderbook of £0.6 million, market guidance will not be impacted.

40 fathoms
09/12/2022
04:57
That is very odd. There was no obvious material information disclosed on the call. Unless it is something mundane, like the video needed to be reedited, it would have to be that they mistakenly provided some incorrect information or the NOMAD objected to the upbeat tone of the presentation vs the subdued near term outlook.
40 fathoms
08/12/2022
18:06
Nahh no luck. I see what you mean but I can't find any other version.
casholaa
08/12/2022
17:04
Casholaa

This is the link from Investor meet Company tweet:


and YouTube:

cliffpeat
08/12/2022
16:34
odd. do you have a url for the youtube vid???
casholaa
08/12/2022
16:13
Watching the interesting FY 2022 company presentation on YouTube "Investor Meet Company" this afternoon when it was suddenly taken down - apparently withdrawn "This video has been removed by the uploader".

Does anyone know why?

Is the presentation available on any other platform?

Was there some "inside" information disclosed?

cliffpeat
07/12/2022
09:24
Todays RNS in my view is close to delusional and in no way reflects the objective state of the business. That said despite all the puffery the chairman did manage to slip in "2023 will see a short-term contraction in revenues" ..... so did 2022.

So they know 2023 is going to be worse than 2022. So lets review the STRONG 2022

Revenue - Down
Gross Profit - Down
Gross Margin - Down
EBITDA - Down
Operating Profit - Down
Profit Per Share - Down
Order Book - Down
Cash - Down
Net Assets - Up (because the capitalised some GBP 2.3 million of development costs, without this capitalisation the company would have reported a loss in excess of GBP 1 million)

They have also admitted, as I have highlighted before that in order to pick up any significant work in Alzheimer's they need to make additional investment and that will only pay off over an extended time period, as any clinical program that is already in flight will not switch providers or approach. The resulting nature of this you are filling the funnel with low value Phase I trails at this time.

They need to win one but prefferably two very large contracts and very soon if they are have chance of avoiding an additional and significant fall in the share price.

Without this happening in the next 6 months and using the maxim that it is better to raise when you can than when you have to a chunky CR in the second half of next year is likely.

40 fathoms
07/12/2022
07:41
Strong transformation with improvements in all areas beating expectations. Now we are set for a steady increase with some huge contracts in the pipeline. 2023 looking strong and with 70p target worth topping up at these levels. Some say 95p target..
halfpenny
27/10/2022
01:48
Unless they sign some very large contracts, very soon they are going to bleed cash in 2023. Based on the trading update at GBP 8.6 million revenue and GBP 1.5 million they were cashflow negative to the tune of GBP 900k. Revenue for FY 2023 is forecast to fall to 7 million.

For what its worth the Chief Commercial Officer hire from 2.5 years ago, Lammert Albers, who was considered an important enough hire to RNS and to roll out on Proactive Investors, quit during the summer.

If the boards and senior executive team are not shaken up soon this will be taken out and for a lot less than its intrinsic worth.

40 fathoms
20/9/2022
08:39
Fathoms, I agree but sales are ramping up and new customers are seeing the value in the solution. American companies increases interest in IXICO. Their technology application does set them apart. American Takeover gets more likely with strong Dollar. Watch this space…
halfpenny
17/9/2022
04:05
@halfpenny - I think you might be right about a takeover.

Even-though the business will not grow revenue in FY2023 and probably not in FY2024 and it also has a neutral book to bill ratio, it could be made instantly profitable on a go forward basis by stripping out the listing costs and replacing the c suite, who are possibly the most overpaid team in the microcap AIM space. The compensation of the CEO, CFO and CBO, for no progress over the last three years, borders on the obscene.

I strongly suspect a bid below 50p would be successful, however still profitable for you given you recent entry point.

40 fathoms
13/9/2022
11:03
IXI chart looking strong with Higher Highs and Higher lows. Extremely positive so I expect once 60p breaks then its Happy times ahead. The 100p and above can be achieved with a Takeover offer which may also be in the pipeline with the Dollar being High...Interesting times ahead for IXI....
halfpenny
12/9/2022
08:12
IXI looks like a strong takeover target at these levels. IXI results show its great future with high demand for their products and services. The next generation product is evolving so future is bright. Adding more getting ready for liftoff soon with RNS release.
halfpenny
01/9/2022
08:55
The management have delivered, well done. With improved sales, software and demand increasing IXI have a strong future. Just added and looking forward to future contract wins. Wot a turnaround by the management team.
halfpenny
01/9/2022
08:02
Very positive update.
Interesting company.
hmmm

thelongandtheshortandthetall
12/8/2022
15:43
Eh oop la - signs of life?
toffeeman
19/6/2022
13:28
The management is justifying its share price by talking about P/S ratios.. i think they should focus on the business.. the stock price will take care of itself.. this product doesn't seem to be as mission critical as the management is portraying it to be..
srinik1988
26/5/2022
09:33
Wot a turnaround well done!!
halfpenny
Chat Pages: 28  27  26  25  24  23  22  21  20  19  18  17  Older

Your Recent History

Delayed Upgrade Clock